Influence of childhood trauma on diagnosis and substance use in first-episode psychosis

S Tomassi¹, S Tosato², V Mondelli¹, C Faravelli¹, A Lasalvia¹, G Fioravanti¹, C Bonetto¹, A Fioritti¹, C Cremonese¹, R Lo Parrino¹, K De Santi¹, A Meneghelli¹, S Torresani¹, G De Girolamo¹, E Semrov¹, M Pratelli¹, D Cristofalo¹, M Ruggeri¹; GET UP Group

Affiliations

¹ Simona Tomassi, MD, Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona; Sarah Tosato, MD PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, and Unit of Psychiatry, Azienda Ospedaliera Universitaria Integrata Verona (AOUI), Verona; Valeria Mondelli, MD PhD, Department of Psychological Medicine, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK; Carlo Faravelli, MD, Department of Psychiatry, University of Firenze, Florence; Antonio Lasalvia, MD PhD, Unit of Psychiatry, AOUI, Verona; Giulia Fioravanti, PhD, Department of Psychiatry, University of Firenze, Florence; Chiara Bonetto, PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona; Angelo Fioritti, MD, Department of Mental Health, Azienda Unità Sanitario Locale (AUSL) Bologna, Bologna; Carla Cremonese, MD, Unit of Psychiatry, Azienda Ospedaliera Padova, Padua; Riccardo Lo Parrino, MD, Department of Mental Health, Florence; Katia De Santi, MD, Unit of Psychiatry, AOUI, Verona; Anna Meneghelli, Ospedale Niguarda Ca' Granda Milano, MHD Programma 2000, Milan; Stefano Torresani, MD, Department of Mental Health, Bolzano; Giovanni De Girolamo, MD, St John of God Clinical Research Centre of Brescia, Brescia; Enrico Semrov, MD, Department of Mental Health, Reggio Emilia; Michela Pratelli, MD, Department of Mental Health, Riccione; Doriana Cristofalo, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona; Mirella Ruggeri, MD PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, and Unit of Psychiatry, AOUI, Verona, Italy; the GET UP Group.
² Simona Tomassi, MD, Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona; Sarah Tosato, MD PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, and Unit of Psychiatry, Azienda Ospedaliera Universitaria Integrata Verona (AOUI), Verona; Valeria Mondelli, MD PhD, Department of Psychological Medicine, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK; Carlo Faravelli, MD, Department of Psychiatry, University of Firenze, Florence; Antonio Lasalvia, MD PhD, Unit of Psychiatry, AOUI, Verona; Giulia Fioravanti, PhD, Department of Psychiatry, University of Firenze, Florence; Chiara Bonetto, PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona; Angelo Fioritti, MD, Department of Mental Health, Azienda Unità Sanitario Locale (AUSL) Bologna, Bologna; Carla Cremonese, MD, Unit of Psychiatry, Azienda Ospedaliera Padova, Padua; Riccardo Lo Parrino, MD, Department of Mental Health, Florence; Katia De Santi, MD, Unit of Psychiatry, AOUI, Verona; Anna Meneghelli, Ospedale Niguarda Ca' Granda Milano, MHD Programma 2000, Milan; Stefano Torresani, MD, Department of Mental Health, Bolzano; Giovanni De Girolamo, MD, St John of God Clinical Research Centre of Brescia, Brescia; Enrico Semrov, MD, Department of Mental Health, Reggio Emilia; Michela Pratelli, MD, Department of Mental Health, Riccione; Doriana Cristofalo, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona; Mirella Ruggeri, MD PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, and Unit of Psychiatry, AOUI, Verona, Italy; the GET UP Group sarah.tosato@univr.it.

PMID: 28729356
DOI: 10.1192/bjp.bp.116.194019

Randomized Controlled Trial

Influence of childhood trauma on diagnosis and substance use in first-episode psychosis

S Tomassi et al. Br J Psychiatry. 2017 Sep.

. 2017 Sep;211(3):151-156.

doi: 10.1192/bjp.bp.116.194019. Epub 2017 Jul 20.

Authors

Affiliations

¹ Simona Tomassi, MD, Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona; Sarah Tosato, MD PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, and Unit of Psychiatry, Azienda Ospedaliera Universitaria Integrata Verona (AOUI), Verona; Valeria Mondelli, MD PhD, Department of Psychological Medicine, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK; Carlo Faravelli, MD, Department of Psychiatry, University of Firenze, Florence; Antonio Lasalvia, MD PhD, Unit of Psychiatry, AOUI, Verona; Giulia Fioravanti, PhD, Department of Psychiatry, University of Firenze, Florence; Chiara Bonetto, PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona; Angelo Fioritti, MD, Department of Mental Health, Azienda Unità Sanitario Locale (AUSL) Bologna, Bologna; Carla Cremonese, MD, Unit of Psychiatry, Azienda Ospedaliera Padova, Padua; Riccardo Lo Parrino, MD, Department of Mental Health, Florence; Katia De Santi, MD, Unit of Psychiatry, AOUI, Verona; Anna Meneghelli, Ospedale Niguarda Ca' Granda Milano, MHD Programma 2000, Milan; Stefano Torresani, MD, Department of Mental Health, Bolzano; Giovanni De Girolamo, MD, St John of God Clinical Research Centre of Brescia, Brescia; Enrico Semrov, MD, Department of Mental Health, Reggio Emilia; Michela Pratelli, MD, Department of Mental Health, Riccione; Doriana Cristofalo, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona; Mirella Ruggeri, MD PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, and Unit of Psychiatry, AOUI, Verona, Italy; the GET UP Group.
² Simona Tomassi, MD, Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona; Sarah Tosato, MD PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, and Unit of Psychiatry, Azienda Ospedaliera Universitaria Integrata Verona (AOUI), Verona; Valeria Mondelli, MD PhD, Department of Psychological Medicine, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK; Carlo Faravelli, MD, Department of Psychiatry, University of Firenze, Florence; Antonio Lasalvia, MD PhD, Unit of Psychiatry, AOUI, Verona; Giulia Fioravanti, PhD, Department of Psychiatry, University of Firenze, Florence; Chiara Bonetto, PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona; Angelo Fioritti, MD, Department of Mental Health, Azienda Unità Sanitario Locale (AUSL) Bologna, Bologna; Carla Cremonese, MD, Unit of Psychiatry, Azienda Ospedaliera Padova, Padua; Riccardo Lo Parrino, MD, Department of Mental Health, Florence; Katia De Santi, MD, Unit of Psychiatry, AOUI, Verona; Anna Meneghelli, Ospedale Niguarda Ca' Granda Milano, MHD Programma 2000, Milan; Stefano Torresani, MD, Department of Mental Health, Bolzano; Giovanni De Girolamo, MD, St John of God Clinical Research Centre of Brescia, Brescia; Enrico Semrov, MD, Department of Mental Health, Reggio Emilia; Michela Pratelli, MD, Department of Mental Health, Riccione; Doriana Cristofalo, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona; Mirella Ruggeri, MD PhD, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, and Unit of Psychiatry, AOUI, Verona, Italy; the GET UP Group sarah.tosato@univr.it.

PMID: 28729356
DOI: 10.1192/bjp.bp.116.194019

Abstract

BackgroundChildhood trauma has been significantly associated with first-episode psychosis, affective dysfunction and substance use.AimsTo test whether people with first-episode psychosis who had experienced childhood trauma, when compared with those who had not, showed a higher rate of affective psychosis and an increased lifetime rate of substance use.MethodThe sample comprised 345 participants with first-episode psychosis (58% male, mean age 29.8 years, s.d. = 9.7).ResultsSevere sexual abuse was significantly associated with a diagnosis of affective psychosis (χ² = 4.9, P = 0.04) and with higher rates of lifetime use of cannabis (68% v 41%; P = 0.02) and heroin (20% v 5%; P = 0.02). Severe physical abuse was associated with increased lifetime use of heroin (15% v 5%; P = 0.03) and cocaine (32% v 17%; P = 0.05).ConclusionsPatients with first-episode psychosis exposed to childhood trauma appear to constitute a distinctive subgroup in terms of diagnosis and lifetime substance use.

PubMed Disclaimer

Conflict of interest statement

Declaration of interestNone.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Cambridge University Press
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Influence of childhood trauma on diagnosis and substance use in first-episode psychosis

Affiliations

Influence of childhood trauma on diagnosis and substance use in first-episode psychosis

Authors

Affiliations

Abstract

Conflict of interest statement

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical